Who invested in Epiodyne?
Epiodyne's investors include Menlo Ventures and Mission BioCapital.
Who invested in Epiodyne
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2021, from 1 source
- Latest round
- VentureMar 2021
- Investors
- 2
The rounds
- Mar 2021
Founders and team
From Epiodyne's own website and the SEC filings it signed: 1 founder, 3 on the team.
Stanford MedicineCo-founder & CEO
- Mike TaylorExecutive Chair
- Alex TkachenkoExecutive Officer, Directori
- Brook ByersExecutive Chair
On the board, as filediDouglas Crawford
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Epiodyne as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Epiodyne
How much has Epiodyne raised?
Epiodyne has raised 1 round since 2021, none with a disclosed amount.
When did Epiodyne last raise?
Epiodyne's most recent round was a Venture in Mar 2021.
Who backed Epiodyne first?
Epiodyne's first round on record, in Mar 2021, was backed by Menlo Ventures and Mission BioCapital.
What stage is Epiodyne at?
Epiodyne's latest named round is a Venture, in Mar 2021.
Companies like Epiodyne
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.